β2 adrenergic receptor polymorphisms and COPD exacerbations: a complicated story.
作者信息
Labaki Wassim W, Han MeiLan K
机构信息
Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA
出版信息
Thorax. 2019 Oct;74(10):927-928. doi: 10.1136/thoraxjnl-2019-213697. Epub 2019 Sep 3.
Abstract
摘要
相似文献
1
β2 adrenergic receptor polymorphisms and COPD exacerbations: a complicated story.
Thorax. 2019 Oct;74(10):927-928. doi: 10.1136/thoraxjnl-2019-213697. Epub 2019 Sep 3.
2
Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
Lancet Respir Med. 2014 Jan;2(1):44-53. doi: 10.1016/S2213-2600(13)70248-0. Epub 2013 Dec 5.
3
Beta-adrenergic receptor gene haplotypes and bronchodilator response in Egyptian patients with chronic obstructive pulmonary disease.
Adv Med Sci. 2017 Mar;62(1):193-201. doi: 10.1016/j.advms.2016.07.008. Epub 2017 Mar 17.
4
Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.
Chest. 2007 Nov;132(5):1485-92. doi: 10.1378/chest.07-1103. Epub 2007 Sep 21.
5
Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD.
Med Sci Monit. 2008 Aug;14(8):CR392-8.
6
Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
Chin Med J (Engl). 2012 Jun;125(12):2213-8.
7
Polymorphisms of the beta2 adrenoreceptor gene in chronic obstructive pulmonary disease.
Ther Adv Respir Dis. 2009 Feb;3(1):3-10. doi: 10.1177/1753465809102553.
8
Changes in biomarkers of cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease.
Respir Med. 2018 Dec;145:192-199. doi: 10.1016/j.rmed.2018.11.008. Epub 2018 Nov 14.
9
Association of beta2-adrenoreceptor genotypes with bronchodilatory effect of tiotropium in COPD.
Respirology. 2008 May;13(3):346-52. doi: 10.1111/j.1440-1843.2008.01259.x.
10
Pharmacogenetics of chronic obstructive pulmonary disease.
Pharmacogenomics. 2013 Jul;14(10):1215-25. doi: 10.2217/pgs.13.107.
引用本文的文献
1
The Combination of Hemogram Indexes to Predict Exacerbation in Stable Chronic Obstructive Pulmonary Disease.
Front Med (Lausanne). 2020 Dec 9;7:572435. doi: 10.3389/fmed.2020.572435. eCollection 2020.
本文引用的文献
1
β-Adrenergic genotypes and risk of severe exacerbations in COPD: a prospective cohort study.
Thorax. 2019 Oct;74(10):934-940. doi: 10.1136/thoraxjnl-2018-212340. Epub 2019 Sep 3.
2
The prevalence of PI*S and PI*Z SERPINA1 alleles in healthy individuals and COPD patients in Saudi Arabia: A case-control study.
Medicine (Baltimore). 2017 Oct;96(42):e8320. doi: 10.1097/MD.0000000000008320.
3
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
Lancet Respir Med. 2017 Aug;5(8):619-626. doi: 10.1016/S2213-2600(17)30207-2. Epub 2017 Jun 28.
4
Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.
Nat Genet. 2017 Mar;49(3):416-425. doi: 10.1038/ng.3787. Epub 2017 Feb 6.
5
Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med. 2017 Feb 1;195(3):324-330. doi: 10.1164/rccm.201605-1014OC.
6
Prediction of acute respiratory disease in current and former smokers with and without COPD.
Chest. 2014 Oct;146(4):941-950. doi: 10.1378/chest.13-2946.
7
Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis.
Lancet Respir Med. 2014 Mar;2(3):214-25. doi: 10.1016/S2213-2600(14)70002-5. Epub 2014 Feb 7.
8
Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
Lancet Respir Med. 2014 Jan;2(1):44-53. doi: 10.1016/S2213-2600(13)70248-0. Epub 2013 Dec 5.
9
ADRB2 polymorphisms and budesonide/formoterol responses in COPD.
Chest. 2012 Aug;142(2):320-328. doi: 10.1378/chest.11-1655.
10
Susceptibility to exacerbation in chronic obstructive pulmonary disease.
N Engl J Med. 2010 Sep 16;363(12):1128-38. doi: 10.1056/NEJMoa0909883.
Zotero 插件